Vaccine Safety Forum -- Copyright -- Preface -- Contents -- Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary -- EXECUTIVE SUMMARY -- INTRODUCTION -- DIFFICULTIES IN DETECTING ADVERSE EVENTS FOLLOWING VACCINATION -- CURRENT ADVERSE EVENT DETECTION AND RESPONSE PROCEDURES -- Vaccine Adverse Event Reporting System -- Large Linked Databases -- Surveillance by Vaccine Manufacturers -- Food and Drug Administration -- IMPROVING DETECTION OF AND RESPONSE TO ADVERSE EVENTS -- Increasing Reporting to VAERS -- Improving the Quality of Information in VAERS -- Improving Vaccine Lot Information -- Improving the Usefulness of LLDB Data -- Clinical Trials -- Comparison Studies -- ADDITIONAL AREAS FOR RESEARCH -- REFERENCES -- WORKSHOP AGENDA -- INSTITUTE OF MEDICINE VACCINE SAFETY FORUM -- PARTICIPANTS -- Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention -- EXECUTIVE SUMMARY -- INTRODUCTION -- IMMUNE RESPONSE TO VACCINE ANTIGENS -- Premature Infants -- GENETIC FACTORS AFFECTING DEVELOPMENT OF AUTOIMMUNITY -- RESEARCH ON IDENTIFYING POPULATIONS AT RISK FOR ADVERSE EVENTS -- Arthritis and Rubella Vaccine -- Anaphylaxis and Measles, Mumps, and Rubella Vaccine -- Convulsions and DPT -- High-Titer Measles Vaccine -- Multiple Sclerosis or Guillain-Barre Syndrome and Vaccines -- Multiple-Antigen Vaccination and Adverse Immune Responses -- RESEARCH OPPORTUNITIES -- REFERENCES -- WORKSHOP AGENDA -- INSTITUTE OF MEDICINE VACCINE SAFETY FORUM -- PARTICIPANTS.